文献速递甲状腺疾病

分化型甲状腺癌的种族差异:我们弥合了差距吗?

Racial Disparities in Differentiated Thyroid Cancer: Have We Bridged the Gap?
PubMed 文献 · Thyroid · 2017-04-19

基于美国国家癌症数据库1998-2012年282,043例分化型甲状腺癌手术患者,分析不同种族在甲状腺切除范围和放射性碘治疗适当性上的时间趋势。黑人相比白人接受适当手术的比值更低(OR=0.78),少数族裔放射性碘治疗不足的可能性更高,且所有种族放射性碘过度治疗均增加。

要点

  • 黑人相比白人接受适当甲状腺切除术的比值更低(OR=0.78,95%CI 0.71-0.87;p<0.001)。
  • 少数族裔放射性碘治疗不足的可能性高于白人:西班牙裔OR=1.27、黑人OR=1.26、亚裔OR=1.25(p<0.001)。
  • 1998年至2012年,黑人和白人接受适当甲状腺切除术的比例分别从78%升至88%、从81%升至91%。

核心结论

  • 分化型甲状腺癌的手术和放射性碘治疗适当利用率随时间改善,但黑人接受适当甲状腺手术的比例始终低于白人。
  • 研究期间所有种族的放射性碘过度治疗均增加。
  • 需要努力在少数族裔患者中标准化分化型甲状腺癌的诊疗。

研究设计与样本

  • 回顾性队列研究,纳入美国国家癌症数据库1998-2012年接受手术的成年分化型甲状腺癌患者282,043例。
  • 采用多变量逻辑回归模型评估不同种族与接受适当手术范围及放射性碘治疗(包括治疗不足和过度治疗)的调整关联。

主要发现

  • 黑人相比白人接受适当手术的比值更低(OR=0.78,95%CI 0.71-0.87;p<0.001)。
  • 适当放射性碘治疗在黑人中高于白人(OR=1.07,95%CI 1.02-1.12;p=0.01),在西班牙裔中低于白人(OR=0.90,95%CI 0.86-0.95;p<0.001)。
  • 放射性碘治疗不足的可能性在少数族裔中高于白人:西班牙裔OR=1.27、黑人OR=1.26、亚裔OR=1.25(p<0.001)。
  • 放射性碘过度治疗的可能性在少数族裔中低于白人:西班牙裔OR=0.89、黑人OR=0.83、亚裔OR=0.79(p<0.001)。
  • 1998年与2012年相比,接受适当甲状腺切除术的比例:黑人78% vs 88%,白人81% vs 91%。

关键数值与推荐

  • 适当手术范围:黑人相比白人OR=0.78(95%CI 0.71-0.87;p<0.001)。
  • 适当放射性碘治疗:黑人相比白人OR=1.07(95%CI 1.02-1.12;p=0.01),西班牙裔相比白人OR=0.90(95%CI 0.86-0.95;p<0.001)。
  • 放射性碘治疗不足:西班牙裔OR=1.27、黑人OR=1.26、亚裔OR=1.25(均p<0.001,均相比白人)。
  • 放射性碘过度治疗:西班牙裔OR=0.89、黑人OR=0.83、亚裔OR=0.79(均p<0.001,均相比白人)。
  • 放射性碘治疗不足比例1998年 vs 2012年:白人48% vs 29%,黑人51% vs 33%,西班牙裔51% vs 37%,亚裔55% vs 39%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Racial disparities in the management of differentiated thyroid cancer (DTC) exist in the United States. There is a paucity of data examining their temporal trends. It was hypothesized that racial disparities in care provided to patients with DTC have improved over the past 15 years. METHODS: Adult patients undergoing surgery for DTC were included from the National Cancer Data Base (1998-2012). Temporal trends in appropriate extent of thyroidectomy and radioactive iodine therapy (RAI) were described for different racial groups. Multivariable logistic regression models were employed to estimate the adjusted association of receipt of appropriate extent of surgery and RAI, specifically under- and over-treatment, among different racial groups. RESULTS: Among 282,043 DTC patients, 80.3% were non-Hispanic white (white), 8.1% Hispanic, 7.2% non-Hispanic black (black), and 4.4% Asian. Black versus white race/ethnicity was associated with lower odds of receiving appropriate surgery (odds ratio [OR] = 0.78 [confidence interval (CI) 0.71-0.87]; p < 0.001). Appropriate RAI treatment was higher in blacks (OR = 1.07 [CI 1.02-1.12]; p = 0.01) and lower for Hispanics (OR = 0.90 [CI 0.86-0.95]; p < 0.001) compared with whites. There was a higher likelihood of RAI under-treatment in minority groups (Hispanic OR = 1.27, black OR = 1.26, Asian OR = 1.25; p < 0.001), and a lower likelihood of RAI over-treatment (Hispanic OR = 0.89, black OR = 0.83, Asian OR = 0.79; p < 0.001) compared with whites. Over time, an increasing proportion of black and white patients underwent appropriate extent of thyroidectomy (1998 vs. 2012: 78% vs. 88% and 81% vs. 91%, respectively). Compared with 1998, fewer patients in 2012 were under-treated with RAI: whites (48% vs. 29%, respectively), blacks (51% vs. 33%), Hispanics (51% vs. 37%), and Asians (55% vs. 39%). The extent of RAI over-treatment increased (1998 vs. 2012): whites (1% vs. 4%), blacks (2% vs. 4%), Hispanics (2% vs. 4%), and Asians (2% vs. 3%), respectively. CONCLUSIONS: Appropriate utilization of surgery and RAI for DTC has improved over time. However, the proportion of patients receiving appropriate thyroid surgery is consistently lower for blacks compared with whites. RAI over-treatment increased for all races over the study period. Efforts are needed to standardize DTC care among minority patients.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Shah SA, Adam MA, Thomas SM, et al. Racial Disparities in Differentiated Thyroid Cancer: Have We Bridged the Gap? Thyroid. 2017. PMID: 28294040. doi:10.1089/thy.2016.0626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。